Amyloid-ß peptides and tau protein as biomarkers in cerebrospinal and interstitial fluid following traumatic brain injury: A review of experimental and clinical studies

Frontiers in Neurology

Volumn 4 JUN, Issue , 2013, Pages

  Tsitsopoulos, Parmenion P ^a,b   Marklund, Niklas ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Alzheimer's disease; Amyloid beta; Biomarkers; Cerebrospinal fluid; Microdialysis; Tau; Traumatic brain injury

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; TAU PROTEIN;

ALZHEIMER DISEASE; ANATOMICAL CONCEPTS; CEREBROSPINAL FLUID ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; HYPERPHOSPHORYLATION; INTERSTITIAL FLUID; MICRODIALYSIS; NEUROFIBRILLARY TANGLE; NONHUMAN; PATHOLOGY; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN PHOSPHORYLATION; REVIEW; TRAUMATIC BRAIN INJURY;

EID: 84883540356     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2013.00079     Document Type: Review

References (161)

1. Abrahamson, E. E., Ikonomovic, M. D., Ciallella, J. R., Hope, C. E., Paljug, W. R., Isanski, B. A., et al. (2006). Caspase inhibition therapy abolishes brain trauma-induced increases in Abeta peptide: implications for clinical outcome. Exp. Neurol. 197, 437-450. doi:10.1016/j.expneurol.2005.10.011
2. Abrahamson, E. E., Ikonomovic, M. D., Dixon, C. E., and Dekosky, S. T. (2009). Simvastatin therapy prevents brain trauma-induced increases in beta-amyloid peptide levels. Ann. Neurol. 66, 407-414. doi:10.1002/ana.21731
3. Adams, J. H., Doyle, D., Ford, I., Gennarelli, T. A., Graham, D. I., and McLellan, D. R. (1989). Diffuse axonal injury in head injury: definition, diagnosis and grading. Histopathology 15, 49-59. doi:10.1111/j.1365-2559.1989.tb03040.x
4. Alonso, A., Zaidi, T., Novak, M., Grundke-Iqbal, I., and Iqbal, K. (2001). Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc. Natl. Acad. Sci. U.S.A. 98, 6923-6928. doi:10.1073/pnas.121119298
5. Bateman, R. J., Wen, G., Morris, J. C., and Holtzman, D. M. (2007). Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker. Neurology 68, 666-669. doi:10.1212/01.wnl.0000256043.50901.e3
6. Bellander, B. M., Cantais, E., Enblad, P., Hutchinson, P., Nordstrom, C. H., Robertson, C., et al. (2004). Consensus meeting on microdialysis in neurointensive care. Intensive Care Med. 30, 2166-2169. doi:10.1007/s00134-004-2461-8
7. Berman, D. E., Dall'armi, C., Voronov, S. V., McIntire, L. B., Zhang, H., Moore, A. Z., et al. (2008). Oligomeric amyloid-beta peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism. Nat. Neurosci. 11, 547-554. doi:10.1038/nn.2100
8. Blasko, I., Beer, R., Bigl, M., Apelt, J., Franz, G., Rudzki, D., et al. (2004). Experimental traumatic brain injury in rats stimulates the expression, production and activity of Alzheimer's disease beta-secretase (BACE-1). J. Neural Transm. 111, 523-536. doi:10.1007/s00702-003-0095-6
9. Blennow, K., De Leon, M. J., and Zetterberg, H. (2006). Alzheimer's disease. Lancet 368, 387-403. doi:10.1016/S0140-6736(06)69113-7
10. Blennow, K., and Hampel, H. (2003). CSF markers for incipient Alzheimer's disease. Lancet Neurol. 2, 605-613. doi:10.1016/S1474-4422(03)00530-1
11. Blennow, K., and Nellgard, B. (2004). Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury. Neurology 62, 159. [author reply 159-160]. doi:10.1212/WNL.62.1.159
12. Breteler, M. M., Claus, J. J., Van Duijn, C. M., Launer, L. J., and Hofman, A. (1992). Epidemiology of Alzheimer's disease. Epidemiol. Rev. 14, 59-82.
13. Brightman, M. W., and Kaya, M. (2000). Permeable endothelium and the interstitial space of brain. Cell. Mol. Neurobiol. 20, 111-130.
14. Brody, D. L., Magnoni, S., Schwetye, K. E., Spinner, M. L., Esparza, T. J., Stocchetti, N., et al. (2008). Amyloid-beta dynamics correlate with neurological status in the injured human brain. Science 321, 1221-1224. doi:10.1126/science.1161591
15. Cai, H., Wang, Y., McCarthy, D., Wen, H., Borchelt, D. R., Price, D. L., et al. (2001). BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat. Neurosci. 4, 233-234. doi:10.1038/85064
16. Chen, X. H., Johnson, V. E., Uryu, K., Trojanowski, J. Q., and Smith, D. H. (2009). A lack of amyloid beta plaques despite persistent accumulation of amyloid beta in axons of long-term survivors of traumatic brain injury. Brain Pathol. 19, 214-223. doi:10.1111/j.1750-3639.2008.00176.x
17. Chen, X. H., Siman, R., Iwata, A., Meaney, D. F., Trojanowski, J. Q., and Smith, D. H. (2004). Long-term accumulation of amyloid-beta, beta-secretase, presenilin-1, and caspase-3 in damaged axons following brain trauma. Am. J. Pathol. 165, 357-371. doi:10.1016/S0002-9440(10)63303-2
18. Ciallella, J. R., Ikonomovic, M. D., Paljug, W. R., Wilbur, Y. I., Dixon, C. E., Kochanek, P. M., et al. (2002). Changes in expression of amyloid precursor protein and interleukin-1beta after experimental traumatic brain injury in rats. J. Neurotrauma 19, 1555-1567. doi:10.1089/089771502762300229
19. Cirrito, J. R., Kang, J. E., Lee, J., Stewart, F. R., Verges, D. K., Silverio, L. M., et al. (2008). Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron 58, 42-51. doi:10.1016/j.neuron.2008.02.003
20. Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., et al. (2005). Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48, 913-922. doi:10.1016/j.neuron.2005.10.028
21. Claeysen, S., Cochet, M., Donneger, R., Dumuis, A., Bockaert, J., and Giannoni, P. (2012). Alzheimer culprits: cellular crossroads and interplay. Cell. Signal. 24, 1831-1840. doi:10.1016/j.cellsig.2012.05.008
22. Clinton, J., Ambler, M. W., and Roberts, G. W. (1991). Post-traumatic Alzheimer's disease: preponderance of a single plaque type. Neuropathol. Appl. Neurobiol. 17, 69-74. doi:10.1111/j.1365-2990.1991.tb00695.x
23. Conte, V., Uryu, K., Fujimoto, S., Yao, Y., Rokach, J., Longhi, L., et al. (2004). Vitamin E reduces amyloidosis and improves cognitive function in Tg2576 mice following repetitive concussive brain injury. J. Neurochem. 90, 758-764. doi:10.1111/j.1471-4159.2004.02560.x
24. Corsellis, J. A., Bruton, C. J., and Freeman-Browne, D. (1973). The aftermath of boxing. Psychol. Med. 3, 270-303. doi:10.1017/S0033291700049588
25. Czeiter, E., Mondello, S., Kovacs, N., Sandor, J., Gabrielli, A., Schmid, K., et al. (2012). Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator. J. Neurotrauma 29, 1770-1778. doi:10.1089/neu.2011.2127
26. Czeiter, E., Pal, J., Kovesdi, E., Bukovics, P., Luckl, J., Doczi, T., et al. (2008). Traumatic axonal injury in the spinal cord evoked by traumatic brain injury. J. Neurotrauma 25, 205-213. doi:10.1089/neu.2007.0331
27. Dale, G. E., Leigh, P. N., Luthert, P., Anderton, B. H., and Roberts, G. W. (1991). Neurofibrillary tangles in dementia pugilistica are ubiquitinated. J. Neurol. Neurosurg. Psychiatr. 54, 116-118. doi:10.1136/jnnp.54.2.116
28. DeKosky, S. T., Abrahamson, E. E., Ciallella, J. R., Paljug, W. R., Wisniewski, S. R., Clark, R. S., et al. (2007). Association of increased cortical soluble abeta42 levels with diffuse plaques after severe brain injury in humans. Arch. Neurol. 64, 541-544. doi:10.1001/archneur.64.4.541
29. Dickstein, D. L., Brautigam, H., Stockton, S. D. Jr., Schmeidler, J., and Hof, P. R. (2010). Changes in dendritic complexity and spine morphology in transgenic mice expressing human wild-type tau. Brain Struct. Funct. 214, 161-179. doi:10.1007/s00429-010-0245-1
30. Emmerling, M. R., Morganti-Kossmann, M. C., Kossmann, T., Stahel, P. F., Watson, M. D., Evans, L. M., et al. (2000). Traumatic brain injury elevates the Alzheimer's amyloid peptide A beta 42 in human CSF. A possible role for nerve cell injury. Ann. N. Y. Acad. Sci. 903, 118-122. doi:10.1111/j.1749-6632.2000.tb06357.x
31. Farias, G., Cornejo, A., Jimenez, J., Guzman, L., and Maccioni, R. B. (2011). Mechanisms of tau self-aggregation and neurotoxicity. Curr. Alzheimer Res. 8, 608-614. doi:10.2174/156720511796717258
32. Feijoo, C., Campbell, D. G., Jakes, R., Goedert, M., and Cuenda, A. (2005). Evidence that phosphorylation of the microtubule-associated protein Tau by SAPK4/p38delta at Thr50 promotes microtubule assembly. J. Cell. Sci. 118, 397-408. doi:10.1242/jcs.01655
33. Fins, J. J. (2003). Constructing an ethical stereotaxy for severe brain injury: balancing risks, benefits and access. Nat. Rev. Neurosci. 4, 323-327. doi:10.1038/nrn1079
34. Fishman, R. (1992). Cerebrospinal Fluid in Diseases of the Nervous System. Philadelphia: Elsevier.
35. Fleminger, S., Oliver, D. L., Lovestone, S., Rabe-Hesketh, S., and Giora, A. (2003). Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication. J. Neurol. Neurosurg. Psychiatr. 74, 857-862. doi:10.1136/jnnp.74.7.857
36. Frankfort, S. V., Tulner, L. R., Van Campen, J. P., Verbeek, M. M., Jansen, R. W., and Beijnen, J. H. (2008). Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literature. Curr. Clin. Pharmacol. 3, 123-131. doi:10.2174/157488408784293723
37. Franz, G., Beer, R., Kampfl, A., Engelhardt, K., Schmutzhard, E., Ulmer, H., et al. (2003). Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury. Neurology 60, 1457-1461. doi:10.1212/01.WNL.0000063313.57292.00
38. Funke, S. A. (2011). Detection of soluble amyloid-beta oligomers and insoluble high-molecular-weight particles in CSF: development of methods with potential for diagnosis and therapy monitoring of Alzheimer's disease. Int. J. Alzheimers Dis. 2011, 151645. doi:10.4061/2011/151645
39. Gabbita, S. P., Scheff, S. W., Menard, R. M., Roberts, K., Fugaccia, I., and Zemlan, F. P. (2005). Cleaved-tau: a biomarker of neuronal damage after traumatic brain injury. J. Neurotrauma 22, 83-94. doi:10.1089/neu.2005.22.83
40. Geddes, J. F., Vowles, G. H., Nicoll, J. A., and Revesz, T. (1999). Neuronal cytoskeletal changes are an early consequence of repetitive head injury. Acta Neuropathol. 98, 171-178. doi:10.1007/s004010051066
41. Genis, L., Chen, Y., Shohami, E., and Michaelson, D. M. (2000). Tau hyperphosphorylation in apolipoprotein E-deficient and control mice after closed head injury. J. Neurosci. Res. 60, 559-564. doi:10.1002/(SICI)1097-4547(20000515)60:4<559::AIDJNR15>;3.0.CO;2-K
42. Gennarelli, T. A., Thibault, L. E., Adams, J. H., Graham, D. I., Thompson, C. J., and Marcincin, R. P. (1982). Diffuse axonal injury and traumatic coma in the primate. Ann. Neurol. 12, 564-574. doi:10.1002/ana.410120611
43. Gentleman, S. M., Greenberg, B. D., Savage, M. J., Noori, M., Newman, S. J., Roberts, G. W., et al. (1997). A beta 42 is the predominant form of amyloid beta-protein in the brains of short-term survivors of head injury. Neuroreport 8, 1519-1522. doi:10.1097/00001756-199704140-00039
44. Gentleman, S. M., Nash, M. J., Sweeting, C. J., Graham, D. I., and Roberts, G. W. (1993). Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci. Lett. 160, 139-144. doi:10.1016/0304-3940(93)90398-5
45. Gouras, G. K., Tampellini, D., Takahashi, R. H., and Capetillo-Zarate, E. (2010). Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease. Acta Neuropathol. 119, 523-541. doi:10.1007/s00401-010-0679-9
46. Gualtieri, T., and Cox, D. R. (1991). The delayed neurobehavioural sequelae of traumatic brain injury. Brain Inj. 5, 219-232. doi:10.3109/02699059109008093
47. Guo, Z., Cupples, L. A., Kurz, A., Auerbach, S. H., Volicer, L., Chui, H., et al. (2000). Head injury and the risk of AD in the MIRAGE study. Neurology 54, 1316-1323. doi:10.1212/WNL.54.6.1316
48. Hansson, O., Zetterberg, H., Buchhave, P., Andreasson, U., Londos, E., Minthon, L., et al. (2007). Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment. Dement. Geriatr. Cogn. Disord. 23, 316-320. doi:10.1159/000100926
49. Hard, T. (2011). Protein engineering to stabilize soluble amyloid beta-protein aggregates for structural and functional studies. FEBS J. 278, 3884-3892. doi:10.1111/j.1742-4658.2011.08295.x
50. Hardy, J., and Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. doi:10.1126/science.1072994
51. Hartman, R. E., Laurer, H., Longhi, L., Bales, K. R., Paul, S. M., Mcintosh, T. K., et al. (2002). Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease. J. Neurosci. 22, 10083-10087.
52. Helisalmi, S., Hiltunen, M., Vepsalainen, S., Iivonen, S., Mannermaa, A., Lehtovirta, M., et al. (2004). Polymorphisms in neprilysin gene affect the risk of Alzheimer's disease in Finnish patients. J. Neurol. Neurosurg. Psychiatr. 75, 1746-1748. doi:10.1136/jnnp.2004.036574
53. Hillered, L., and Persson, L. (1999). Neurochemical monitoring of the acutely injured human brain. Scand. J. Clin. Lab. Invest. Suppl. 229, 9-18. doi:10.1080/00365519950185904
54. Hillered, L., Vespa, P. M., and Hovda, D. A. (2005). Translational neurochemical research in acute human brain injury: the current status and potential future for cerebral microdialysis. J. Neurotrauma 22, 3-41. doi:10.1089/neu.2005.22.3
55. Hillman, J., Milos, P., Yu, Z. Q., Sjogren, F., Anderson, C., and Mellergard, P. (2006). Intracerebral microdialysis in neurosurgical intensive care patients utilising catheters with different molecular cut-off (20 and 100 kD). Acta Neurochir. (Wien) 148, 319-324; discussion 324. doi:10.1007/s00701-005-0670-8
56. Hof, P. R., Bouras, C., Buee, L., Delacourte, A., Perl, D. P., and Morrison, J. H. (1992). Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases. Acta Neuropathol. 85, 23-30. doi:10.1007/BF00304630
57. Hong, S., Quintero-Monzon, O., Ostaszewski, B. L., Podlisny, D. R., Cavanaugh, W. T., Yang, T., et al. (2011). Dynamic analysis of amyloid beta-protein in behaving mice reveals opposing changes in ISF versus parenchymal Abeta during age-related plaque formation. J. Neurosci. 31, 15861-15869. doi:10.1523/JNEUROSCI.3272-11.2011
58. Horsburgh, K., Cole, G. M., Yang, F., Savage, M. J., Greenberg, B. D., Gentleman, S. M., et al. (2000). Beta-amyloid (Abeta)42(43), abeta42, abeta40 and apoE immunostaining of plaques in fatal head injury. Neuropathol. Appl. Neurobiol. 26, 124-132. doi:10.1046/j.1365-2990.2000.026002124.x
59. Hoshino, S., Tamaoka, A., Takahashi, M., Kobayashi, S., Furukawa, T., Oaki, Y., et al. (1998). Emergence of immunoreactivities for phosphorylated tau and amyloid-beta protein in chronic stage of fluid percussion injury in rat brain. Neuroreport 9, 1879-1883. doi:10.1097/00001756-199806010-00039
60. Hutchinson, P. J., O'Connell, M. T., Nortje, J., Smith, P., Al-Rawi, P. G., Gupta, A. K., et al. (2005). Cerebral microdialysis methodology - evaluation of 20 kDa and 100 kDa catheters. Physiol. Meas. 26, 423-428. doi:10.1088/0967-3334/26/4/008
61. Ikonomovic, M. D., Uryu, K., Abrahamson, E. E., Ciallella, J. R., Trojanowski, J. Q., Lee, V. M., et al. (2004). Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp. Neurol. 190, 192-203. doi:10.1016/j.expneurol.2004.06.011
62. Iliff, J. J., Wang, M., Lioa, Y., Plogg, B. A., Peng, W., Gundersen, G. A., et al. (2012). A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid ß. Sci. Transl. Med. 15, 147ra111. doi:10.1126/scitranslmed.3003748
63. Itoh, T., Satou, T., Nishida, S., Tsubaki, M., Hashimoto, S., and Ito, H. (2009). Expression of amyloid precursor protein after rat traumatic brain injury. Neurol. Res. 31, 103-109. doi:10.1179/016164108X323771
64. Iwata, A., Chen, X. H., Mcintosh, T. K., Browne, K. D., and Smith, D. H. (2002). Long-term accumulation of amyloid-beta in axons following brain trauma without persistent upregulation of amyloid precursor protein genes. J. Neuropathol. Exp. Neurol. 61, 1056-1068.
65. Johnson, V. E., Stewart, W., Graham, D. I., Stewart, J. E., Praestgaard, A. H., and Smith, D. H. (2009). A neprilysin polymorphism and amyloid-beta plaques after traumatic brain injury. J. Neurotrauma 26, 1197-1202. doi:10.1089/neu.2008-0843
66. Johnson, V. E., Stewart, W., and Smith, D. H. (2010). Traumatic brain injury and amyloid-beta pathology: a link to Alzheimer's disease? Nat. Rev. Neurosci. 11, 361-370. doi:10.1038/nrn2808
67. Johnson, V. E., Stewart, W., and Smith, D. H. (2012). Widespread tau and amyloid-Beta pathology many years after a single traumatic brain injury in humans. Brain Pathol. 22, 142-149. doi:10.1111/j.1750-3639.2011.00513.x
68. Jordan, B. D., Kanik, A. B., Horwich, M. S., Sweeney, D., Relkin, N. R., Petito, C. K., et al. (1995). Apolipoprotein E epsilon 4 and fatal cerebral amyloid angiopathy associated with dementia pugilistica. Ann. Neurol. 38, 698-699. doi:10.1002/ana.410380429
69. Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., et al. (2003). APP processing and synaptic function. Neuron 37, 925-937. doi:10.1016/S0896-6273(03)00124-7
70. Kay, A. D., Petzold, A., Kerr, M., Keir, G., Thompson, E., and Nicoll, J. A. (2003). Alterations in cerebrospinal fluid apolipoprotein E and amyloid beta-protein after traumatic brain injury. J. Neurotrauma 20, 943-952. doi:10.1089/089771503321532824
71. Kennedy, R. E., Schneider, L. S., Cutter, G. R., and Alzheimer's Disease Neuroimaging Initiative. (2012). Biomarker positive and negative subjects in the ADNI cohort: clinical characterization. Curr. Alzheimer Res. 9, 1135-1141. doi:10.2174/156720512804142976
72. Kim, J., Basak, J. M., and Holtzman, D. M. (2009). The role of apolipoprotein E in Alzheimer's disease. Neuron 63, 287-303. doi:10.1016/j.neuron.2009.06.026
73. Koffie, R. M., Hashimoto, T., Tai, H. C., Kay, K. R., Serrano-Pozo, A., Joyner, D., et al. (2012). Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-beta. Brain 135, 2155-2168. doi:10.1093/brain/aws127
74. Kovesdi, E., Czeiter, E., Tamas, A., Reglodi, D., Szellar, D., Pal, J., et al. (2007). Rescuing neurons and glia: is inhibition of apoptosis useful? Prog. Brain Res. 161, 81-95. doi:10.1016/S0079-6123(06)61006-6
75. Kovesdi, E., Luckl, J., Bukovics, P., Farkas, O., Pal, J., Czeiter, E., et al. (2010). Update on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics. Acta Neurochir. (Wien) 152, 1-17. doi:10.1007/s00701-009-0463-6
76. LaFerla, F. M., Green, K. N., and Oddo, S. (2007). Intracellular amyloid-beta in Alzheimer's disease. Nat. Rev. Neurosci. 8, 499-509. doi:10.1038/nrn2168
77. Lazarov, O., Morfini, G. A., Lee, E. B., Farah, M. H., Szodorai, A., Deboer, S. R., et al. (2005). Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: revisited. J. Neurosci. 25, 2386-2395. doi:10.1523/JNEUROSCI.3089-04.2005
78. Le, M. N., Kim, W., Lee, S., McKee, A. C., and Hall, G. F. (2012). Multiple mechanisms of extracellular tau spreading in a non-transgenic tauopathy model. Am. J. Neurodegener. Dis. 1, 316-333.
79. Lewen, A., Li, G. L., Nilsson, P., Olsson, Y., and Hillered, L. (1995). Traumatic brain injury in rat produces changes of beta-amyloid precursor protein immunoreactivity. Neuroreport 6, 357-360. doi:10.1097/00001756-199501000-00032
80. Liliang, P. C., Liang, C. L., Lu, K., Wang, K. W., Weng, H. C., Hsieh, C. H., et al. (2010a). Relationship between injury severity and serum tau protein levels in traumatic brain injured rats. Resuscitation 81, 1205-1208. doi:10.1016/j.resuscitation.2010.05.016
81. Liliang, P. C., Liang, C. L., Weng, H. C., Lu, K., Wang, K. W., Chen, H. J., et al. (2010b). Tau proteins in serum predict outcome after severe traumatic brain injury. J. Surg. Res. 160, 302-307. doi:10.1016/j.jss.2008.12.022
82. Loane, D. J., Pocivavsek, A., Moussa, C. E., Thompson, R., Matsuoka, Y., Faden, A. I., et al. (2009). Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury. Nat. Med. 15, 377-379. doi:10.1038/nm.1940
83. Magnoni, S., and Brody, D. L. (2010). New perspectives on amyloid-beta dynamics after acute brain injury: moving between experimental approaches and studies in the human brain. Arch. Neurol. 67, 1068-1073. doi:10.1001/archneurol.2010.214
84. Magnoni, S., Esparza, T. J., Conte, V., Carbonara, M., Carrabba, G., Holtzman, D. M., et al. (2012). Tau elevations in the brain extracellular space correlate with reduced amyloid-beta levels and predict adverse clinical outcomes after severe traumatic brain injury. Brain 135, 1268-1280. doi:10.1093/brain/awr286
85. Mannix, R. C., Zhang, J., Park, J., Lee, C., and Whalen, M. J. (2011). Detrimental effect of genetic inhibition of B-site APP-cleaving enzyme 1 on functional outcome after controlled cortical impact in young adult mice. J. Neurotrauma 28, 1855-1861. doi:10.1089/neu.2011.1759
86. Marklund, N., Blennow, K., Zetterberg, H., Ronne-Engstrom, E., Enblad, P., and Hillered, L. (2009). Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury. J. Neurosurg. 110, 1227-1237. doi:10.3171/2008.9.JNS08584
87. Marklund, N., and Hillered, L. (2011). Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here? Br. J. Pharmacol. 164, 1207-1229. doi:10.1111/j.1476-5381.2010.01163.x
88. Masters, C. L., Cappai, R., Barnham, K. J., and Villemagne, V. L. (2006). Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics. J. Neurochem. 97, 1700-1725. doi:10.1111/j.1471-4159.2006.03989.x
89. Mattson, M. P. (2004). Pathways towards and away from Alzheimer's disease. Nature 430, 631-639. doi:10.1038/nature02621
90. Mattsson, N., Zegers, I., Andreasson, U., Bjerke, M., Blankenstein, M. A., Bowser, R., et al. (2012). Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid beta42. Biomark. Med. 6, 409-417. doi:10.2217/bmm.12.39
91. Mayeux, R., Ottman, R., Tang, M. X., Noboa-Bauza, L., Marder, K., Gurland, B., et al. (1993). Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives. Ann. Neurol. 33, 494-501. doi:10.1002/ana.410330513
92. McKee, A. C., Cantu, R. C., Nowinski, C. J., Hedley-Whyte, E. T., Gavett, B. E., Budson, A. E., et al. (2009). Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J. Neuropathol. Exp. Neurol. 68, 709-735. doi:10.1097/NEN.0b013e3181a9d503
93. McKee, A. C., Stein, T. D., Nowinski, C. J., Stern, R. A., Daneshvar, D. H., Alvarez, V. E., et al. (2013). The spectrum of disease in chronic traumatic encephalopathy. Brain 136, 43-64.
94. McKenzie, K. J., McLellan, D. R., Gentleman, S. M., Maxwell, W. L., Gennarelli, T. A., and Graham, D. I. (1996). Is beta-APP a marker of axonal damage in short-surviving head injury? Acta Neuropathol. 92, 608-613. doi:10.1007/s004010050568
95. Meaney, D. F., Smith, D. H., Shreiber, D. I., Bain, A. C., Miller, R. T., Ross, D. T., et al. (1995). Biomechanical analysis of experimental diffuse axonal injury. J. Neurotrauma 12, 689-694. doi:10.1089/neu.1995.12.689
96. Mehta, P. D., Pirttila, T., Mehta, S. P., Sersen, E. A., Aisen, P. S., and Wisniewski, H. M. (2000). Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease. Arch. Neurol. 57, 100-105. doi:10.1001/archneur.57.1.100
97. Meyer-Luehmann, M., Stalder, M., Herzig, M. C., Kaeser, S. A., Kohler, E., Pfeifer, M., et al. (2003). Extracellular amyloid formation and associated pathology in neural grafts. Nat. Neurosci. 6, 370-377. doi:10.1038/nn1022
98. Morales, D. M., Marklund, N., Lebold, D., Thompson, H. J., Pitkanen, A., Maxwell, W. L., et al. (2005). Experimental models of traumatic brain injury: do we really need to build a better mousetrap? Neuroscience 136, 971-989. doi:10.1016/j.neuroscience.2005.08.030
99. Morris, M., Maeda, S., Vossel, K., and Mucke, L. (2011). The many faces of tau. Neuron 70, 410-426. doi:10.1016/j.neuron.2011.04.009
100. Mortimer, J. A., Van Duijn, C. M., Chandra, V., Fratiglioni, L., Graves, A. B., Heyman, A., et al. (1991). Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int. J. Epidemiol. 20(Suppl. 2), S28-S35. doi:10.1093/ije/20.Supplement_2.S28
101. Murai, H., Pierce, J. E., Raghupathi, R., Smith, D. H., Saatman, K. E., Trojanowski, J. Q., et al. (1998). Twofold overexpression of human beta-amyloid precursor proteins in transgenic mice does not affect the neuromotor, cognitive, or neurodegenerative sequelae following experimental brain injury. J. Comp. Neurol. 392, 428-438. doi:10.1002/(SICI)1096-9861(19980323)392:4<428::AIDCNE2>;3.0.CO;2-2
102. Murakami, N., Yamaki, T., Iwamoto, Y., Sakakibara, T., Kobori, N., Fushiki, S., et al. (1998). Experimental brain injury induces expression of amyloid precursor protein, which may be related to neuronal loss in the hippocampus. J. Neurotrauma 15, 993-1003. doi:10.1089/neu.1998.15.993
103. Nakagawa, Y., Nakamura, M., McIntosh, T. K., Rodriguez, A., Berlin, J. A., Smith, D. H., et al. (1999). Traumatic brain injury in young, amyloid-beta peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Abeta deposition during aging. J. Comp. Neurol. 411, 390-398. doi:10.1002/(SICI)1096-9861(19990830)411:3<390::AIDCNE3>;3.3.CO;2-R
104. Nakagawa, Y., Reed, L., Nakamura, M., Mcintosh, T. K., Smith, D. H., Saatman, K. E., et al. (2000). Brain trauma in aged transgenic mice induces regression of established abeta deposits. Exp. Neurol. 163, 244-252. doi:10.1006/exnr.2000.7375
105. Neselius, S., Brisby, H., Theodorsson, A., Blennow, K., Zetterberg, H., and Marcusson, J. (2012). CSF-biomarkers in Olympic boxing: diagnosis and effects of repetitive head trauma. PLoS ONE 7:e33606. doi:10.1371/journal.pone.0033606
106. Nicoll, J. A., Roberts, G. W., and Graham, D. I. (1995). Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. Nat. Med. 1, 135-137. doi:10.1038/nm0295-135
107. Nowak, L. A., Smith, G. G., and Reyes, P. F. (2009). Dementia in a retired world boxing champion: case report and literature review. Clin. Neuropathol. 28, 275-280.
108. Ojo, J. O., Mouzon, B., Greenberg, M. B., Bachmeier, C., Mullan, M., and Crawford, F. (2013). Repetitive mild traumatic brain injury augments tau pathology and glial activation in aged hTau mice. J. Neuropathol. Exp. Neurol. 72, 137-151. doi:10.1097/NEN.0b013e3182814cdf
109. Olsson, A., Cajbok, L., Ost, M., Höglund, K., Nylén, K., Rosengren, L., et al. (2004). Marked increase of beta-amyloid (1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury. J. Neurol. 251, 870-876. doi:10.1007/s00415-004-0451-y
110. Ost, M., Nylen, K., Csajbok, L., Ohrfelt, A. O., Tullberg, M., Wikkelso, C., et al. (2006). Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury. Neurology 67, 1600-1604. doi:10.1212/01.wnl.0000242732.06714.0f
111. Otsuka, N., Tomonaga, M., and Ikeda, K. (1991). Rapid appearance of beta-amyloid precursor protein immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury. Brain Res. 568, 335-338. doi:10.1016/0006-8993(91)91422-W
112. Parihar, M. S., and Brewer, G. J. (2010). Amyloid-beta as a modulator of synaptic plasticity. J. Alzheimers Dis. 22, 741-763. doi:10.3233/JAD-2010-101020
113. Pierce, J. E., Trojanowski, J. Q., Graham, D. I., Smith, D. H., and Mcintosh, T. K. (1996). Immunohistochemical characterization of alterations in the distribution of amyloid precursor proteins and beta-amyloid peptide after experimental brain injury in the rat. J. Neurosci. 16, 1083-1090.
114. Plassman, B. L., Havlik, R. J., Steffens, D. C., Helms, M. J., Newman, T. N., Drosdick, D., et al. (2000). Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology 55, 1158-1166. doi:10.1212/WNL.55.8.1158
115. Povlishock, J. T., Erb, D. E., and Astruc, J. (1992). Axonal response to traumatic brain injury: reactive axonal change, deafferentation, and neuroplasticity. J. Neurotrauma 9(Suppl. 1), S189-S200.
116. Price, D. L., Sisodia, S. S., and Gandy, S. E. (1995). Amyloid beta amyloidosis in Alzheimer's disease. Curr. Opin. Neurol. 8, 268-274. doi:10.1097/00019052-199508000-00004
117. Quigley, H., Colloby, S. J., and O'Brien, J. T. (2011). PET imaging of brain amyloid in dementia: a review. Int. J. Geriatr. Psychiatry 26, 991-999. doi:10.1002/gps.2640
118. Raby, C. A., Morganti-Kossmann, M. C., Kossmann, T., Stahel, P. F., Watson, M. D., Evans, L. M., et al. (1998). Traumatic brain injury increases beta-amyloid peptide 1-42 in cerebrospinal fluid. J. Neurochem. 71, 2505-2509. doi:10.1046/j.1471-4159.1998.71062505.x
119. Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., and Ferreira, A. (2002). Tau is essential to beta -amyloid-induced neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 99, 6364-6369. doi:10.1073/pnas.092136199
120. Roberts, G. W., Allsop, D., and Bruton, C. (1990). The occult aftermath of boxing. J. Neurol. Neurosurg. Psychiatr. 53, 373-378. doi:10.1136/jnnp.53.5.373
121. Roberts, G. W., Gentleman, S. M., Lynch, A., Murray, L., Landon, M., and Graham, D. I. (1994). Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatr. 57, 419-425. doi:10.1136/jnnp.57.4.419
122. Rostami, E., Davidsson, J., Ng, K. C., Lu, J., Gyorgy, A., Walker, J., et al. (2012). A model for mild traumatic brain injury that induces limited transient memory impairment and increased levels of axon related serum biomarkers. Front. Neurol. 3:115. doi:10.3389/fneur.2012.00115
123. Saatman, K. E., Duhaime, A. C., Bullock, R., Maas, A. I., Valadka, A., and Manley, G. T. (2008). Classification of traumatic brain injury for targeted therapies. J. Neurotrauma 25, 719-738. doi:10.1089/neu.2008.0586
124. Schwetye, K. E., Cirrito, J. R., Esparza, T. J., Mac Donald, C. L., Holtzman, D. M., and Brody, D. L. (2010). Traumatic brain injury reduces soluble extracellular amyloid-beta in mice: a methodologically novel combined microdialysis-controlled cortical impact study. Neurobiol. Dis. 40, 555-564. doi:10.1016/j.nbd.2010.06.018
125. Selkoe, D. J. (1989). Biochemistry of altered brain proteins in Alzheimer's disease. Annu. Rev. Neurosci. 12, 463-490. doi:10.1146/annurev.ne.12.030189.002335
126. Selkoe, D. J., and Schenk, D. (2003). Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu. Rev. Pharmacol. Toxicol. 43, 545-584. doi:10.1146/annurev.pharmtox.43.100901.140248
127. Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., et al. (1992). Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 359, 325-327. doi:10.1038/359325a0
128. Shaw, G. J., Jauch, E. C., and Zemlan, F. P. (2002). Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury. Ann. Emerg. Med. 39, 254-257. doi:10.1067/mem.2002.121214
129. Sivanandam, T. M., and Thakur, M. K. (2012). Traumatic brain injury: a risk factor for Alzheimer's disease. Neurosci. Biobehav. Rev. 36, 1376-1381. doi:10.1016/j.neubiorev.2012.02.013
130. Smith, C., Graham, D. I., Murray, L. S., and Nicoll, J. A. (2003a). Tau immunohistochemistry in acute brain injury. Neuropathol. Appl. Neurobiol. 29, 496-502. doi:10.1046/j.1365-2990.2003.00488.x
131. Smith, D. H., Chen, X. H., Iwata, A., and Graham, D. I. (2003b). Amyloid beta accumulation in axons after traumatic brain injury in humans. J. Neurosurg. 98, 1072-1077. doi:10.3171/jns.2003.98.5.1072
132. Smith, D. H., Meaney, D. F., and Shull, W. H. (2003c). Diffuse axonal injury in head trauma. J. Head Trauma Rehabil. 18, 307-316. doi:10.1097/00001199-200307000-00003
133. Smith, D. H., Chen, X. H., Nonaka, M., Trojanowski, J. Q., Lee, V. M., Saatman, K. E., et al. (1999). Accumulation of amyloid beta and tau and the formation of neurofilament inclusions following diffuse brain injury in the pig. J. Neuropathol. Exp. Neurol. 58, 982-992. doi:10.1097/00005072-199909000-00008
134. Smith, D. H., Chen, X. H., Xu, B. N., McIntosh, T. K., Gennarelli, T. A., and Meaney, D. F. (1997). Characterization of diffuse axonal pathology and selective hippocampal damage following inertial brain trauma in the pig. J. Neuropathol. Exp. Neurol. 56, 822-834. doi:10.1097/00005072-199707000-00009
135. Smith, D. H., and Meaney, D. F. (2000). Axonal damage in traumatic brain injury. Neuroscientist 6, 483-495. doi:10.1177/107385840000600611
136. Smith, D. H., Nakamura, M., McIntosh, T. K., Wang, J., Rodriguez, A., Chen, X. H., et al. (1998). Brain trauma induces massive hippocampal neuron death linked to a surge in beta-amyloid levels in mice overexpressing mutant amyloid precursor protein. Am. J. Pathol. 153, 1005-1010. doi:10.1016/S0002-9440(10)65643-X
137. Sola, C., Garcia-Ladona, F. J., Sarasa, M., Mengod, G., Probst, A., Palacios, G., et al. (1993). Beta APP gene expression is increased in the rat brain after motor neuron axotomy. Eur. J. Neurosci. 5, 795-808. doi:10.1111/j.1460-9568.1993.tb00931.x
138. Stalder, M., Phinney, A., Probst, A., Sommer, B., Staufenbiel, M., and Jucker, M. (1999). Association of microglia with amyloid plaques in brains of APP23 transgenic mice. Am. J. Pathol. 154, 1673-1684. doi:10.1016/S0002-9440(10)65423-5
139. Stone, J. R., Okonkwo, D. O., Singleton, R. H., Mutlu, L. K., Helm, G. A., and Povlishock, J. T. (2002). Caspase-3-mediated cleavage of amyloid precursor protein and formation of amyloid Beta peptide in traumatic axonal injury. J. Neurotrauma 19, 601-614. doi:10.1089/089771502753754073
140. Strich, S. J. (1956). Diffuse degeneration of the cerebral white matter in severe dementia following head injury. J. Neurol. Neurosurg. Psychiatr. 19, 163-185. doi:10.1136/jnnp.19.3.163
141. Strozyk, D., Blennow, K., White, L. R., and Launer, L. J. (2003). CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology 60, 652-656. doi:10.1212/01.WNL.0000046581.81650.D0
142. Texido, L., Hernandez, S., Martin-Satue, M., Povedano, M., Casanovas, A., Esquerda, J., et al. (2011). Sera from amyotrophic lateral sclerosis patients induce the non-canonical activation of NMDA receptors "in vitro". Neurochem. Int. 59, 954-964. doi:10.1016/j.neuint
143. Tian, L., Guo, R., Yue, X., Lv, Q., Ye, X., Wang, Z., et al. (2012). Intranasal administration of nerve growth factor ameliorate beta-amyloid deposition after traumatic brain injury in rats. Brain Res. 1440, 47-55. doi:10.1016/j.brainres.2011.12.059
144. Tran, H. T., Laferla, F. M., Holtzman, D. M., and Brody, D. L. (2011a). Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-beta accumulation and independently accelerates the development of tau abnormalities. J. Neurosci. 31, 9513-9525. doi:10.1523/JNEUROSCI.0858-11.2011
145. Tran, H. T., Sanchez, L., Esparza, T. J., and Brody, D. L. (2011b). Distinct temporal and anatomical distributions of amyloid-beta and tau abnormalities following controlled cortical impact in transgenic mice. PLoS ONE 6:e25475. doi:10.1371/journal.pone.0025475
146. Tran, H. T., Sanchez, L., and Brody, D. L. (2012). Inhibition of JNK by a peptide inhibitor reduces traumatic brain injury-induced tauopathy in transgenic mice. J. Neuropathol. Exp. Neurol. 71, 116-129. doi:10.1097/NEN.0b013e3182456aed
147. Trojanowski, J. Q., Schuck, T., Schmidt, M. L., and Lee, V. M. (1989). Distribution of tau proteins in the normal human central and peripheral nervous system. J. Histochem. Cytochem. 37, 209-215. doi:10.1177/37.2.2492045
148. Trojanowski, J. Q., Vandeerstichele, H., Korecka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., et al. (2010). Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimers Dement. 6, 230-238. doi:10.1016/j.jalz.2010.03.008
149. Uryu, K., Chen, X. H., Martinez, D., Browne, K. D., Johnson, V. E., Graham, D. I., et al. (2007). Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans. Exp. Neurol. 208, 185-192. doi:10.1016/j.expneurol.2007.06.018
150. Uryu, K., Laurer, H., McIntosh, T., Pratico, D., Martinez, D., Leight, S., et al. (2002). Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis. J. Neurosci. 22, 446-454.
151. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., et al. (2002). Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539. doi:10.1038/416535a
152. Weiner, M. W., Veitch, D. P., Aisen, P. S., Beckett, L. A., Cairns, N. J., Green, R. C., et al. (2012). The Alzheimer's disease neuroimaging initiative: a review of papers published since its inception. Alzheimers Dement. 8, S1-68. doi:10.1016/j.jalz.2011.09.172
153. Wilhelmsen, K. C. (1999). The tangled biology of tau. Proc. Natl. Acad. Sci. U.S.A. 96, 7120-7121. doi:10.1073/pnas.96.13.7120
154. Yarnell, P., and Ommaya, A. K. (1969). Experimental cerebral concussion in the rhesus monkey. Bull. N. Y. Acad. Med. 45, 39-45.
155. Yoshiyama, Y., Uryu, K., Higuchi, M., Longhi, L., Hoover, R., Fujimoto, S., et al. (2005). Enhanced neurofibrillary tangle formation, cerebral atrophy, and cognitive deficits induced by repetitive mild brain injury in a transgenic tauopathy mouse model. J. Neurotrauma 22, 1134-1141. doi:10.1089/neu.2005.22.1134
156. Yu, F., Wang, Z., Tchantchou, F., Chiu, C. T., Zhang, Y., and Chuang, D. M. (2012a). Lithium ameliorates neurodegeneration, suppresses neuroinflammation, and improves behavioral performance in a mouse model of traumatic brain injury. J. Neurotrauma 29, 362-374. doi:10.1089/neu.2011.1942
157. Yu, F., Zhang, Y., and Chuang, D. M. (2012b). Lithium reduces BACE1 overexpression, beta amyloid accumulation, and spatial learning deficits in mice with traumatic brain injury. J. Neurotrauma 29, 2342-2351. doi:10.1089/neu.2012.2449
158. Zemlan, F. P., Jauch, E. C., Mulchahey, J. J., Gabbita, S. P., Rosenberg, W. S., Speciale, S. G., et al. (2002). C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome. Brain Res. 947, 131-139. doi:10.1016/S0006-8993(02)02920-7
159. Zemlan, F. P., Rosenberg, W. S., Luebbe, P. A., Campbell, T. A., Dean, G. E., Weiner, N. E., et al. (1999). Quantification of axonal damage in traumatic brain injury: affinity purification and characterization of cerebrospinal fluid tau proteins. J. Neurochem. 72, 741-750. doi:10.1046/j.1471-4159.1999.0720741.x
160. Zetterberg, H., Hietala, M. A., Jonsson, M., Andreasen, N., Styrud, E., Karlsson, I., et al. (2006). Neurochemical aftermath of amateur boxing. Arch. Neurol. 63, 1277-1280. doi:10.1001/archneur.63.9.1277
161. Zohar, O., Lavy, R., Zi, X., Nelson, T. J., Hongpaisan, J., Pick, C. G., et al. (2011). PKC activator therapeutic for mild traumatic brain injury in mice. Neurobiol. Dis. 41, 329-337. doi:10.1016/j.nbd.2010.10.001